At Aurigene, we have a well-experienced team that is skilled with global quality and regulatory guidelines to complement your projects with the right set of analytical activities. We have a state-of-the-art analytical lab through which we can develop a variety of analytical methods. We plan the analytical strategy based on the project lifecycle and customer needs. We have capabilities across method verification, development, validation and impurity profiling that includes isolation, identification & characterization and assessment of nitrosamine or other genotoxic impurities. We also conduct stability studies as per ICH guidelines.
Equipments and Techniques
Chromatography Equipments
- HPLC instruments coupled with UV, PDA, ELSD, CAD and RI detectors with Empower 3 software
- GC instruments FID, TCD, ECD detectors with Empower 3 software
- UPLC instruments
- Ion Chromatography
Advanced Characterization Techniques
Mass spectrometer (LC-MS and HR-MS)
- AB Sciex 4500 QQQ instrument
- Waters UPLC with LCT premier XE Time of flight detector
- Agilent HPLC with 6410 triple quad mass detectors
- Agilent GC with 5975C EI/CI Inert XL detector
- UV-Visible spectrophotometer
- FT- IR with UATR
- 400 MHz NMR spectroscopy
- Elemental impurities: Agilent 7800 ICPMS
Solid State Characterization Techniques
- DSC and TGA instruments
- Particle size analyzer: Malvern Master sizer 3000
- Headspace Coulometer, Karl Fischer Analyzer
Preparative Chromatography
- Semi Preparative Instruments
- Preparative Scale Instruments
- Flash Chromatography
- Gel Permeation Chromatography
- Ion Exchange Chromatography
- Bench-Top Lyophilizer
Early Phase
For early phase projects, we develop analytical methods in hand-in-hand with the process development program. For critical quality attributes of the final product such as assay, related substances, and residual solvents analytical methods are verified. Our standard analytical method verification procedures check LOD, LOQ, linearity, precision, specificity, accuracy, robustness, solution stability and mobile phase stability. Along with these verifications, fit-for-purpose analytical methods for testing raw materials, in-process controls, and intermediate analysis are developed. Post mapping of equipment at the manufacturing facility, an appropriate residue method is also developed and validated. We generate and qualify the appropriate quantity of reference standards to support the analysis and method transfers.
Typical characterization of the reference standard includes
- Characterization with appropriate spectroscopic techniques, Mass spectrometry, NMR and FT-IR
- Testing for its impurities (related substances or chromatographic purity) as per the pre-defined test procedure
- Water by KF or loss on drying
- Other parameters such as sulphated ash or residue on ignition (ROI) or residual solvents
- Determination of the potency of the reference standard
- The polymorphic characteristics of the material will be analyzed if it is a specific polymorph
Late Phase
We perform method validation as per the internal SOP of Aurigene against the predefined specification. The method will be validated as per ICH guidelines for parameters like LOD, LOQ, linearity, repeatability, recovery, solution stability, specificity, precision, accuracy, robustness and mobile phase stability. Analytical activities also depend on whether we are working on intermediates, RSM or the final API.
- RSMs - Analytical methods will be developed for the Regulatory Starting Materials (RSMs) and those methods will be validated. The key tests for the KSM would be related substances, assay and residual solvents along with the general tests such as appearance, Identification, water content, etc.
- For Intermediates - For the process validation campaign, analytical method validation for the intermediate stages required was followed by formal method transfer to the quality control site. Hence, we perform the complete method validation against predefined specifications and protocol and a report shall be created as per internal SOPs.
- For API - Analytical methods for the final API step would be validated before the start of manufacturing batches.
We also do the following analytical activities
- Forced degradation study - Specificity of the analytical test procedure will be demonstrated by various stress studies for the final compound in line with ICH guidelines by subjecting the sample to acid, base, peroxide, thermal, and photolytic degradation conditions, and a separate report will be generated for the forced degradation studies.
- Verification for pharmacopeia methods shall be done for identification tests like 1H NMR, 13C NMR, FT-IR, PXRD, DSC test, and water content by KF to confirm the identity test.
- Post mapping of equipment train at the manufacturing facility, appropriate residue method will be developed and validated.
- To support the analysis and method transfers, an appropriate quantity of the reference standard would be generated and qualified.
- Developing sensitive analytical methodology for Potential Genotoxic Impurities (PGI), Nitrosamines, Elemental impurities etc.
- Typical characterization of the reference standard includes:
- Characterization with appropriate spectroscopic techniques, Mass, NMR, and FT-IR
- Testing for its impurities (related substances or chromatographic purity) as per the pre-defined test procedure
- Water by KF or loss on drying
- Other parameters such as sulfated ash or residue on ignition (ROI) or residual solvents
- Determination of the potency of the reference standard
- The polymorphic characteristics of the material will be analyzed if it is a specific polymorph
Method Validation and Stability Studies
We perform analytical validation in compliance with the Pharmacopoeia, current Good Manufacturing Practices (cGMP) and ICH requirements as per customer needs. Following are the salient features of our method validation activities:
- Method validation executed as per the well-defined phase appropriate SOPs which are in line with the current regulatory, ICH guidelines in accordance to cGMP requirements
- Our method validation capability includes KSMs, intermediates, APIs and drug product. SOPs are well defined to suit the phase specification method validation requirements
- Custom-field calculations, e-sign off procedures are enabled for chromatographic instruments to ensure the highest level of compliance.
- Validation activities recorded in to electronic lab notebook enforces online documentation in accordance to principles of ALCOA+
- Completion of validation to meeting stringent timelines
- Method transfer to QC
Stability studies:
We perform stability studies for developmental APIs, intermediates, RSMs and drug products.
- Stability studies as per ICH – Long term, Intermediate and Accelerated condition
- Short term temperature exposure studies
- Photo stability studies
We have the stability chambers, refrigerator and deep fridge storage suiting to requirements of different climatic zone.
Why Aurigene Analytical Development and Validation Development Services?
Expertise in global quality & regulatory guidelines
Phase appropriate standard operating procedures
Dedicated infrastructure
Breadth of analytical services
Expertise in the niche analytical requirements for various technology classes
Virtual Tour
Hyderabad R and D Center
Bangalore R and D Center
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Learning Resources
The importance of business continuity planning in CRDMO industry
Both natural and unnatural catastrophic events inflict negative consequences due to the ever-increasing interconnectedness of the global economy. Those consequences are certain to last for longer duration. e.g.; The Covid-19 pandemic is still having a negative impact on the global economy. Maintaining continuity is critical for all businesses, but perhaps no othe...
Read More
Accelerating Drug Discovery Through Innovative Partnerships
Genomics plays a vital role in identifying which gene is associated with a specific disease. A gene called CNOT1 is for example known for it's effect on brain development and for impairing memory and learning. Despite the great promise genomics provides in understanding the disease, genes are not the best drug targets....
Read More
High Potent API (HPAPI) Manufacturing Services
Aurigene Pharmaceutical Services has experience, expertise and infrastructure to develop and manufacture oncology drug candidates including HPAPI ...
Read More
Systematic formulation design - shorten development cost & time
Project Challenge: Existing formulation (lower strength - 50 mg) was manufactured using direct compression process. This formulation posed poor powder flow and content uniformity issues during scale-up. Development of new strength 150 mg without any process issues was a challenge. Solution design: Preliminary pre-formulation, stress study and PSD impact assessmen...
Read More
A metal catalyst-free and one-pot synthesis of (3,4- dihydro-2H-benzo[b][1,4]oxazin-2-yl)methanol derivatives in water
2015
A robust and metal catalyst-free method has been developed for the general and green synthesis of racemic (3,4-dihydro-2H-benzo[b][1,4] oxazin-2-yl)methanol derivatives. This simple, mild and practical method involves the reaction of 2-aminophenols with ()-epichlorohydrin in the presence of NaOH in water at room temperature. The reaction features high regioselec...
Read More-
Development and assessment of a Bcs class II - SGLT2 (Sodium Glucose Cotransporter 2) inhibitor drug in the form of solid lipid Nanoparticles by selecting different lipids, co-surfactants, and manufacturing techniques
Drug Delivery System (DDS) has been used successfully in the past few decades to cure illnesses and enhance health because of its improved systemic circulation and ability to regulate the drug's pharmacological action. As pharmacology and pharmacokinetics advanced, the idea of controlled release emerged, demonstrating the significance of drug release in assessing...
Read More -
Development of novel paullone-based PROTACs as anticancer agents
Proteolysis-targeting chimera (PROTACs) represents a promising modality that has gained significant attention for cancer treatment. Using PROTAC technology, we synthesized novel structurally modified paullone-based PROTACs using Cereblon (CRBN) and Von Hippel–Lindau (VHL) E3 ligands....
Read More -
Development and verification of RP-HPLC method for the quantitative determination of Decitabine in tablet dosage formulation
Decitabine is an anti-cancer chemotherapy drug. This article describes method development and method verification of Assay of Decitabine in tablet formulation. A new, precise, rapid, accurate RP-HPLC method has been developed for the estimation of Decitabine in pharmaceutical tablets dosage form. After optimization the good chromatographic separation was achieved...
Read More
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market